BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 30

• Genetown

  Cequent Pharmaceuticals, Inc. Closes Tranche of $10.8 Million Round

  November 2, 2009

   · 

  1 min read
• Business

  Natus Medical Incorporated Q3 Tops Estimates, Raises ’09 View

  November 2, 2009

   · 

  1 min read
• Biotech Bay

  Accuray Inc. Introduces the CyberKnife(R) VSI(TM) System New Capabilities Extend CyberKnife Treatment Options to Include Robotic IMRT

  November 2, 2009

   · 

  3 min read
• Drug Development

  Optimer Pharmaceuticals, Inc.: Additional Data From Fidaxomicin’s Phase 3 Study for Clostridium Difficile Infection (CDI) Presented at IDSA Annual Meeting

  November 2, 2009

   · 

  4 min read
• Drug Development

  AEterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer

  November 2, 2009

   · 

  5 min read
• Business

  Perrigo Company Reports Record Earnings and Raises Full Year Adjusted EPS Guidance

  November 2, 2009

   · 

  8 min read
• Genetown

  LFB Biotechnologies Provides $10 Million of Funding To GTC Biotherapeutics

  November 2, 2009

   · 

  4 min read
• Drug Development

  Novavax, Inc. Reports Positive Data for its Trivalent Seasonal Influenza (VLP) Vaccine Candidate in a Second Phase II Study

  November 2, 2009

   · 

  3 min read
• Lone Star Bio

  Bellicum Pharmaceuticals, Inc. Raises $4.5 Million

  November 2, 2009

   · 

  1 min read
• Policy

  superDimension, Inc.: Lung Cancer Diagnosis Breakthrough from superDimension Receives Category I(R) CPT Reimbursement Codes

  November 2, 2009

   · 

  2 min read